Rigel Pharmaceuticals Inc. (RIGL) revealed Loss for second quarter that decreased from the same period last year and beat the Street estimates.
The company's earnings totaled -$1.030 million, or -$0.06 per share. This compares with -$6.600 million, or -$0.38 per share, in last year's second quarter.
Analysts on average had expected the company to earn -$0.29 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 37.0% to $36.841 million from $26.886 million last year.
Rigel Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings (Q2): -$1.030 Mln. vs. -$6.600 Mln. last year.-EPS (Q2): -$0.06 vs. -$0.38 last year.-Revenue (Q2): $36.841 Mln vs. $26.886 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.